Consumer Sovereignty

Consumer Sovereignty in Health Economics

In health economics, consumer sovereignty is an economic principle that lets the people affected by a programme, and nobody else, decide what counts as a benefit to them and how much it is worth. It is the value judgement that allows a cost-benefit analysis to add up the willingness to pay of patients, carers and taxpayers, and setting it aside in favour of health as the outcome is one of the main lines between welfarist and extra-welfarist evaluation. Health care strains the principle more than most markets, because patients often rely on better informed clinicians and because vaccination and unhealthy consumption affect people other than the chooser. The NICE manual (PMG36) and the HM Treasury Green Book (2026) take different positions on whose valuations count, which shapes both technology appraisal and the case for health taxes.

Origins of the term and its place in welfare economics

Persky, in an economic history of the idea, notes that the term is usually traced to William Harold Hutt and his 1936 book Economists and the Public. Hutt's concern was the exercise of power in a free society, and his main defence of consumer sovereignty rested on its role in promoting political and social stability. That defence has largely dropped out of discussion, while the term itself became a normative tenet of welfare economics.

Brouwer and colleagues count individual sovereignty, which their keywords call consumer sovereignty, among the four tenets of the neoclassical framework. It is the view that individuals are themselves the best, and some would say the only, judges of what contributes most to their utility and of how much it contributes. Crisp, writing on well-being, links this to economists coming to see well-being as the satisfaction of preferences revealed by choices. The test of Pareto efficiency rests on the same view, since each person's own ranking decides whether they are better off.

How the principle enters a cost-benefit analysis

Under consumer sovereignty the value of a programme is the sum of what the people affected would pay for it, judged by their own preferences. Cost-benefit analysis puts that into practice by measuring the willingness to pay of everyone who gains and the compensation needed by everyone who loses.

$$NB = \sum_{i=1}^{n} WTP_i - C$$

where $NB$ is the net benefit of the programme, $WTP_i$ is the maximum amount person $i$ would pay for it or, for a person made worse off, minus the compensation that person would need, $n$ is the number of people affected and $C$ is the opportunity cost of the resources it uses.

The HM Treasury Green Book values goods and services by their opportunity cost, starting from market prices (paragraphs 8.1 and 8.2), and ranks non-market methods by reliability with revealed preference above stated preference (paragraph 8.6). Stated preference should be used only when reliable revealed preference data are not available, because survey responses are often biased or inconsistent (paragraph 8.18). The Green Book gives the value of a QALY used by the Department of Health and Social Care, built from surveys of the value people place on health outcomes, as an example of stated preference (paragraph 8.17). Lost consumer surplus counts as a real cost in the same spirit, whatever an expert thinks of the product.

Why health care strains consumer sovereignty

Seixas, in a critical review of welfarism, lists the features of the health care market usually found in textbooks, among them information asymmetry, supplier-induced demand and the derived nature of the demand for health care. A patient who relies on a clinician's advice is choosing through an agent, the subject of the principal-agent problem in healthcare, and the arguments about uncertainty and trust are covered under consumer choice.

Spillovers, or externalities, are a second strain. Seixas cites the anti-vaccination movement, whose members prefer not to vaccinate themselves or their children and so put the wider population at risk. Such vaccination externalities do not by themselves overturn consumer sovereignty, since a sovereign appraisal still counts the welfare of the people harmed, but the chooser's own valuation leaves those harms out.

A third strain comes from doubts about the preferences themselves. Seixas draws on Sen's idea of an inability to desire, under which people in disadvantaged positions hold expectations truncated by limited possibilities, so a welfarist approach can skew resources against them. Hansson and Grüne-Yanoff, writing on preferences, note that the usual answer to misinformed and self-defeating wishes is to launder preferences first, and that if others decide which preferences survive, problems of paternalism are difficult to avoid.

Behavioural evidence that choices may not track welfare

Behavioural economics adds evidence that choices and welfare can come apart. Bernheim and Rangel observe that many behavioural economists separate decision utility, which rationalises choice, from true utility, which captures well-being, a distinction that compels them either to make paternalistic judgements or to adopt some other measure of experienced well-being.

The Green Book makes a related allowance. One of its examples of market failure is imperfect information, where a good may be worse for consumers' wellbeing than they realise in a way market prices do not capture, so its price is too low from a social value perspective (paragraph 8.5). That sentence accepts that a consumer can be wrong about their own welfare, which strict consumer sovereignty denies. Present bias and bounded rationality in diet and smoking are typical health cases.

Libertarian paternalism tries to keep both sides. Dworkin, in the encyclopedia entry on paternalism, explains that the nudges proposed by Sunstein and Thaler change how choices are presented without removing options or attaching significant costs, and that the good promoted is the good as viewed by the agent herself. A choice architecture intervention such as placing healthy food at eye level leaves the choice set intact, although Dworkin records the worry that nudgers may be mistaken about what people really value when they claim people prefer health to more sugary drinks.

Paternalism, merit goods and public funding of health care

Dworkin defines paternalism as interference with a person against their will, defended or motivated by a claim that the person will be better off or protected from harm, with physicians withholding information about a patient's condition as one medical example. Weak paternalism interferes only with means likely to defeat the person's own ends, while strong paternalism also overrides ends judged mistaken or irrational.

Brouwer and colleagues say that Culyer's extra-welfarism rested partly on the idea that judgements might be made on behalf of, rather than by, the affected individuals, which seems especially relevant for public and so-called merit goods. They quote the 1944 white paper A National Health Service, which said that getting the best medical facilities should not depend on whether people can pay for them, and treat such statements by governments as one root of extra-welfarism.

Extra-welfarism, the decision maker and the NICE reference case

Brouwer and colleagues trace another root of extra-welfarism to the decision-making approach of Sugden and Williams, which contrasted the welfarist embodiment of individual sovereignty with an approach in which decision makers are the source of values and weights. Rejecting individual sovereignty in this sense, they add, can concern another objective, such as health, instead of individual utility.

The NICE manual (PMG36) justifies cost-effectiveness analysis by NICE's focus on maximising health gains from a fixed NHS and personal social services budget, with health effects expressed as QALYs (sections 4.2.14 and 4.2.15). Patients report changes in their health-related quality of life, and those changes are valued using public preferences from a representative sample of the UK population with a choice-based method (sections 4.3.1, 4.3.3 and 4.3.4). The public therefore judges how good one health state is compared with another, while the patient's willingness to pay for the treatment plays no part in a cost-utility analysis. Seixas notes the tension this leaves, since QALY weights still treat individuals as the best judges of the dimensions of health.

Worked example of a sugary drinks tax under two welfare judgements

All numbers in this example are illustrative and come from no study. A representative consumer buys 100 cans of a sugary drink a year at GBP 1.00 a can. A tax of GBP 0.20 a can is passed on in full and, along a straight-line demand curve, purchases fall to 80 cans. Each can imposes an external cost of GBP 0.05 on other people, such as taxpayer-funded treatment.

1. Work out the tax revenue. The government collects $R = 0.20 \times 80 = 16$, or GBP 16 a year. The Green Book treats taxes as transfers between the government and the rest of society (paragraph 8.4), so the revenue is not a loss to society.

2. Work out the lost consumer surplus. The consumer loses the tax on the cans still bought plus a triangle on the 20 cans given up.

$$\Delta CS = t \times Q_1 + \frac{1}{2} \times t \times (Q_0 - Q_1)$$

where $\Delta CS$ is the loss of consumer surplus, $t$ is the tax per can, $Q_0$ is the 100 cans bought before the tax and $Q_1$ is the 80 cans bought after it. Here $\Delta CS = 0.20 \times 80 + 0.5 \times 0.20 \times 20 = 18$, or GBP 18. Netting off the GBP 16 transfer leaves a deadweight loss of GBP 2.

3. Add the external saving. The 20 cans not bought avoid external costs of $E = 0.05 \times 20 = 1$, or GBP 1.

4. Apply consumer sovereignty. The consumer is taken to have already weighed the private health harm of GBP 0.15 a can when buying, so no further health gain is counted. The welfare change is $\Delta W = 1 - 2 = -1$, a loss of GBP 1 per consumer a year. The tax is four times the external cost, and a Pigouvian tax matching that cost would be GBP 0.05 a can.

5. Relax consumer sovereignty. Suppose instead the analyst judges, as the Green Book's imperfect information example allows, that consumers ignore a future harm to their own health worth GBP 0.15 a can. The avoided harm is $H = 0.15 \times 20 = 3$, or GBP 3, and the welfare change becomes $\Delta W = 1 + 3 - 2 = 2$, a gain of GBP 2. As a check, the tax now equals the total uncounted harm of GBP 0.20 a can, and the gain equals the triangle $\Delta W = 0.5 \times 0.20 \times 20 = 2$.

6. Interpret the result. The evidence is identical in both judgements, yet the sign of the result flips. The difference comes entirely from whether the consumer's own valuation of the drink is accepted as the measure of the consumer's welfare, so an appraisal of a health tax should state which judgement it makes and report the other in sensitivity analysis.

Consumer sovereignty beside autonomy, preference and social welfare

Autonomy concerns who decides what happens to a person's own body and care, while consumer sovereignty concerns whose valuations count when outcomes are compared, so a payer can respect a patient's right to refuse treatment and still decline to fund an option the patient wants. Preference and revealed preference describe what people rank and choose, and consumer sovereignty is the further normative step of treating those rankings as the measure of welfare. A social welfare function then weighs one person's welfare against another's, a question consumer sovereignty leaves open.

Common misreadings of consumer sovereignty

Three misreadings recur in health economics. Each treats the principle as a description of behaviour or as an absolute rule.

1. Consumer sovereignty is a fact about consumers. It is a value judgement about whose assessments count, and evidence of mistaken choices weakens the case for it without settling it.
2. Externalities refute consumer sovereignty. A sovereign appraisal counts the welfare of everyone affected, so external harms call for correction such as a tax and leave the chooser's view of their own welfare untouched.
3. QALY-based appraisal has abandoned preferences. PMG36 values health states by public preferences, so sovereignty passes to the public as judge of health states while the patient's willingness to pay drops out.

Sources

• Bernheim BD, Rangel A. Beyond revealed preference: choice theoretic foundations for behavioral welfare economics. NBER Working Paper 13737. Cambridge, MA: National Bureau of Economic Research; 2008. https://www.nber.org/papers/w13737
• Brouwer WBF, Culyer AJ, van Exel NJA, Rutten FFH. Welfarism vs. extra-welfarism. Journal of Health Economics. 2008;27(2):325-338. https://doi.org/10.1016/j.jhealeco.2007.07.003
• Crisp R. Well-being. In: The Stanford Encyclopedia of Philosophy. First published 6 November 2001, substantive revision 13 January 2026. https://plato.stanford.edu/entries/well-being/
• Dworkin G. Paternalism. In: The Stanford Encyclopedia of Philosophy. First published 6 November 2002, substantive revision 9 September 2020. https://plato.stanford.edu/entries/paternalism/
• Hansson SO, Grüne-Yanoff T. Preferences. In: The Stanford Encyclopedia of Philosophy. First published 4 October 2006, substantive revision 14 March 2022. https://plato.stanford.edu/entries/preferences/
• HM Treasury. The Green Book: UK government guidance on appraisal. London: HM Treasury; 2026. Chapter 8, paragraphs 8.1, 8.2, 8.4 to 8.6, 8.17 and 8.18. https://www.gov.uk/government/publications/the-green-book--2
• National Institute for Health and Care Excellence. NICE technology appraisal and highly specialised technologies guidance: the manual (PMG36). Published 31 January 2022, last updated 13 October 2026. Sections 4.2.14, 4.2.15, 4.3.1, 4.3.3 and 4.3.4. https://www.nice.org.uk/process/pmg36
• Persky J. Retrospectives: consumer sovereignty. Journal of Economic Perspectives. 1993;7(1):183-191. https://doi.org/10.1257/jep.7.1.183
• Seixas BV. Welfarism and extra-welfarism: a critical overview. Cadernos de Saúde Pública. 2017;33(8):e00014317. https://doi.org/10.1590/0102-311X00014317